Analysis of Poor Prognostic Factors and Treatment Strategies in Platinum-Based Systemic Therapy After EGFR-TKI Failure in Patients With Advanced Nonsmall Cell Lung Cancer Harboring EGFR Mutations.

Hata T, Yamada T, Furuya N, Tanaka H, Yoshimura A, Oba T, Hibino M, Fukuda T, Goto Y, Nakao A, Ogusu S, Okazaki Y, Harada T, Ota T, Masubuchi K, Mikami K, Matsumoto S, Honda R, Date K, Chihara Y, Kawachi H, Morimoto K, Takayama K

Open source

DOI: 10.1016/j.cllc.2025.07.014
Published: 2025 Dec
Container: Clinical lung cancer
Publisher: Not recorded
Open access: unknown

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1016/j.cllc.2025.07.014,
  title = {Analysis of Poor Prognostic Factors and Treatment Strategies in Platinum-Based Systemic Therapy After EGFR-TKI Failure in Patients With Advanced Nonsmall Cell Lung Cancer Harboring EGFR Mutations.},
  author = {Hata T and Yamada T and Furuya N and Tanaka H and Yoshimura A and Oba T and Hibino M and Fukuda T and Goto Y and Nakao A and Ogusu S and Okazaki Y and Harada T and Ota T and Masubuchi K and Mikami K and Matsumoto S and Honda R and Date K and Chihara Y and Kawachi H and Morimoto K and Takayama K},
  year = {2025},
  journal = {Clinical lung cancer},
  doi = {10.1016/j.cllc.2025.07.014},
  url = {https://doi.org/10.1016/j.cllc.2025.07.014}
}

RIS

TY  - JOUR
TI  - Analysis of Poor Prognostic Factors and Treatment Strategies in Platinum-Based Systemic Therapy After EGFR-TKI Failure in Patients With Advanced Nonsmall Cell Lung Cancer Harboring EGFR Mutations.
AU  - Hata T
AU  - Yamada T
AU  - Furuya N
AU  - Tanaka H
AU  - Yoshimura A
AU  - Oba T
AU  - Hibino M
AU  - Fukuda T
AU  - Goto Y
AU  - Nakao A
AU  - Ogusu S
AU  - Okazaki Y
AU  - Harada T
AU  - Ota T
AU  - Masubuchi K
AU  - Mikami K
AU  - Matsumoto S
AU  - Honda R
AU  - Date K
AU  - Chihara Y
AU  - Kawachi H
AU  - Morimoto K
AU  - Takayama K
PY  - 2025
JO  - Clinical lung cancer
DO  - 10.1016/j.cllc.2025.07.014
UR  - https://doi.org/10.1016/j.cllc.2025.07.014
ER  -

APA

T, H., T, Y., N, F., H, T., A, Y., T, O., M, H., T, F., Y, G., A, N., S, O., Y, O., T, H., T, O., K, M., K, M., S, M., R, H., K, D., Y, C., H, K., K, M., & K, T. (2025). Analysis of Poor Prognostic Factors and Treatment Strategies in Platinum-Based Systemic Therapy After EGFR-TKI Failure in Patients With Advanced Nonsmall Cell Lung Cancer Harboring EGFR Mutations.. Clinical lung cancer. https://doi.org/10.1016/j.cllc.2025.07.014

Source records

pubmed · retrieved 2026-09-25T14:53:47.750Z